Cite

HARVARD Citation

    Martinez, C. et al. (n.d.). CHARACTERIZATION OF IMMUNE PHENOTYPES AS PREDICTIVE BIOMARKERS FOR RESPONSE TO THE α4β7 INTEGRIN BLOCKER, VEDOLIZUMAB. Inflammatory bowel diseases. p. S56. [Online]. 
  
Back to record